anonymous
Guest
anonymous
Guest
Anyone from MRL here? How true is the buzz on turning us into a large molecule company? Reorg in the books?
We need to be aggressive in acquisitions, products on market and late stage clinical compounds…we pump billions into R&D, what have our scientists actually come up with? Very little